On Monday, CorMedix Inc (NASDAQ: CRMD) opened higher 21.68%% from the last session, before settling in for the closing price of $13.61. Price fluctuations for CRMD have ranged from $3.61 to $15.38 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 29.80% annually for the last half of the decade. Company’s average yearly earnings per share was noted 435.56% at the time writing. With a float of $65.96 million, this company’s outstanding shares have now reached $67.71 million.
In an organization with 65 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 95.19%, operating margin of 17.53%, and the pretax margin is 20.81%.
CorMedix Inc (CRMD) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of CorMedix Inc is 2.75%, while institutional ownership is 34.73%. The most recent insider transaction that took place on Oct 31 ’24, was worth 14,985. In this transaction EVP, Chief Commercial Officer of this company bought 1,500 shares at a rate of $9.99, taking the stock ownership to the 52,011 shares. Before that another transaction happened on Nov 14 ’24, when Company’s EVP sold 140,027 for $11.18, making the entire transaction worth $1,565,670. This insider now owns 45,397 shares in total.
CorMedix Inc (CRMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 435.56% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
Check out the current performance indicators for CorMedix Inc (CRMD). In the past quarter, the stock posted a quick ratio of 3.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.23, a number that is poised to hit 0.15 in the next quarter and is forecasted to reach 1.71 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
Let’s dig in a bit further. During the last 5-days, its volume was 2.43 million. That was better than the volume of 1.63 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 35.33%.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 92.65%, which indicates a significant increase from 83.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.37% in the past 14 days, which was lower than the 96.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.40, while its 200-day Moving Average is $10.03. However, in the short run, CorMedix Inc’s stock first resistance to watch stands at $17.41. Second resistance stands at $18.26. The third major resistance level sits at $19.09. If the price goes on to break the first support level at $15.73, it is likely to go to the next support level at $14.90. The third support level lies at $14.05 if the price breaches the second support level.
CorMedix Inc (NASDAQ: CRMD) Key Stats
There are currently 67,825K shares outstanding in the company with a market cap of 1.12 billion. Presently, the company’s annual sales total 43,470 K according to its annual income of -17,930 K. Last quarter, the company’s sales amounted to 39,080 K and its income totaled 20,640 K.
